Purchase Order SPE2DP18V0740
- Not listed
- Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award...
- The U.S. government awarded a firm-fixed-price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $85,899.84 contract is to provide blood packs with anticoagulant to the Defense Logistics Agency (DLA), which serves as the medical supply chain for the U.S. Department of Defense. The contract has an ultimate completion date of July 21, 2025 and was awarded on May 22, 2025. Fenwal, Inc. is a registered...
- The U.S. Defense Department's Medical Supply Chain, through its Defense Logistics Agency, awarded a $1,148.65 firm fixed-price purchase order to Fenwal, Inc. for blood collection assemblies. The contract, issued on September 16, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation and represents a competitive award to the prime contractor. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich,...
- This $1,839.04 firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of 8510030904 - BLOOD PACK WITH ANT, a medical supply item used in transfusion medicine and cell therapy applications. Fenwal, a registered government vendor since 2007, has a history of providing a diverse array of...
- This federal contract award, valued at $2,202.56, was issued by the Defense Logistics Agency's Medical Supply Chain division to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the procurement of blood packs with anticoagulant, classified under the product code 8511121932. This is a firm fixed-price purchase order with a period of performance ending on March 17, 2025. The award does not have a set-aside designation, reflecting Fenwal's...
- The Defense Logistics Agency Troop Support Medical awarded a $7,356.16 firm fixed price purchase order to Fenwal, Inc. to deliver blood packs with anticoagulant. The contract has a period of performance from July 24, 2023 through July 31, 2023 with all products to be delivered to Fenwal's facility in Lake Zurich, Illinois. No set aside designation or subcontractors were identified. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring and providing...
- The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on March 25, 2025, for the supply of intravenous fluids for blood bank operations. Valued at $16,608.88 with an ultimate completion date of September 1, 2025, this contract represents a non-set-aside award supporting critical blood banking capabilities. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, will perform this work at Agana...
- The U.S. Defense Logistics Agency awarded a $2,188.92 firm fixed-price purchase order to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the supply of "Washing Solution, FR" to support the agency's medical supply chain operations. This award does not have a set-aside designation. Fenwal has extensive experience providing a wide range of medical supplies and equipment, including blood bags, tubing, solutions, and specialized items,...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,581.75 firm fixed-price purchase order to Fenwal, Inc. for washing solution on January 27, 2026, with an ultimate completion date of May 27, 2026. This contract carries no set-aside designation, reflecting Fenwal's specialized capabilities as the sole source provider for this critical blood banking consumable. Fenwal, a subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, is a global blood technology company that...
- This federal contract award, valued at $2,570.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is a firm fixed-price purchase order for the supply of specialized medical products, such as blood collection assemblies, washing solutions, and apheresis equipment, to support critical healthcare programs, including military medical supply chains, biomedical research...
The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order to Fenwal, Inc. for blood packs with anticoagulant, with a ceiling value of $3,462. The award, issued on July 31, 2018, with an ultimate completion date of August 6, 2018, represents a routine consumable procurement for military medical supply operations. No set-aside designation was used for this acquisition, reflecting Fenwal's established position as a qualified supplier of specialized blood products to the Department of Defense. Fenwal, Inc., a subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, is a recognized supplier of blood collection, processing, and transfusion products to multiple federal health agencies including the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. The company's extensive federal contract portfolio demonstrates its critical role in supporting military medical supply chains and blood banking operations across the government. This purchase order for blood packs with anticoagulant represents part of Fenwal's ongoing provision of essential transfusion medicine consumables that support DOD medical readiness and operational healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/30/18 |